Venkatesh Chelvam

Venkatesh Chelvam

Active Director Additional Director DIN 08979581
DIN 08979581 First appointment Dec 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkatesh Chelvam

Data last updated:

Venkatesh Chelvam is an Additional Director at Roncov Diagnostics And Therapeutics Private Limited (since 2020). The company operates in Healthcare.

DIN 08979581
Primary Designation Additional Director
Industry Healthcare
First Appointment 01 Dec 2020
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director01 Dec 20202019Active

Board colleagues of Venkatesh Chelvam

Directorship timeline

Open interactive timeline →
Roncov Diagnostics And Therapeutics Private Limited
Premium access

Shareholding and investment profile for Venkatesh Chelvam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatesh Chelvam

Venkatesh Chelvam currently holds 1 directorship: Roncov Diagnostics And Therapeutics Private Limited (Additional Director, since 01 Dec 2020).

Venkatesh Chelvam was first appointed on 01 Dec 2020 as Additional Director at Roncov Diagnostics And Therapeutics Private Limited.

The current boards of Venkatesh Chelvam's companies include Lakshmanan Vasanthi (Roncov Diagnostics And Therapeutics Private Limited), Latha (Roncov Diagnostics And Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available